News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279,739 Results
Type
Article (14384)
Company Profile (108)
Press Release (265244)
Multimedia
Podcasts (64)
Webinars (13)
Section
Business (90646)
Career Advice (467)
Deals (16790)
Drug Delivery (70)
Drug Development (37468)
Employer Resources (51)
FDA (6477)
Job Trends (6400)
News (155054)
Policy (14338)
Tag
Academia (466)
Accelerated approval (8)
Adcomms (7)
Allergies (60)
Alliances (24003)
ALS (51)
Alzheimer's disease (462)
Antibody-drug conjugate (ADC) (94)
Approvals (6619)
Artificial intelligence (185)
Autoimmune disease (30)
Automation (9)
Bankruptcy (152)
Best Places to Work (4520)
BIOSECURE Act (9)
Biosimilars (103)
Biotechnology (40)
Bladder cancer (34)
Brain cancer (29)
Breast cancer (156)
Cancer (1253)
Cardiovascular disease (147)
Career advice (417)
Career pathing (13)
CAR-T (44)
CDC (7)
Cell therapy (141)
Cervical cancer (8)
Clinical research (32372)
Collaboration (642)
Compensation (285)
Complete response letters (30)
COVID-19 (785)
CRISPR (40)
C-suite (356)
Cystic fibrosis (57)
Data (1659)
Denatured (18)
Depression (35)
Diabetes (129)
Diagnostics (1515)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (100)
Drug pricing (106)
Drug shortages (12)
Duchenne muscular dystrophy (74)
Earnings (34727)
Editorial (18)
Employer branding (4)
Employer resources (46)
Events (39654)
Executive appointments (525)
FDA (7480)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (389)
Gene editing (64)
Generative AI (14)
Gene therapy (158)
GLP-1 (429)
Government (1401)
Grass and pollen (4)
Guidances (183)
Healthcare (3893)
HIV (9)
Huntington's disease (7)
IgA nephropathy (35)
Immunology and inflammation (65)
Immuno-oncology (5)
Indications (37)
Infectious disease (844)
Inflammatory bowel disease (69)
Inflation Reduction Act (7)
Influenza (22)
Intellectual property (97)
Interviews (60)
IPO (6268)
IRA (33)
Job creations (2088)
Job search strategy (374)
Kidney cancer (9)
Labor market (27)
Layoffs (208)
Leadership (8)
Legal (3502)
Liver cancer (23)
Longevity (7)
Lung cancer (183)
Lymphoma (105)
Machine learning (10)
Management (17)
Manufacturing (354)
MASH (66)
Medical device (1598)
Medtech (1603)
Mergers & acquisitions (10963)
Metabolic disorders (411)
Multiple sclerosis (40)
NASH (15)
Neurodegenerative disease (64)
Neuropsychiatric disorders (24)
Neuroscience (815)
NextGen: Class of 2025 (1704)
Non-profit (614)
Now hiring (16)
Obesity (208)
Opinion (138)
Ovarian cancer (35)
Pain (97)
Pancreatic cancer (46)
Parkinson's disease (69)
Partnered (9)
Patents (202)
Patient recruitment (96)
Peanut (12)
People (29892)
Pharmaceutical (63)
Pharmacy benefit managers (15)
Phase I (8499)
Phase II (13767)
Phase III (12207)
Pipeline (1384)
Policy (124)
Postmarket research (1405)
Preclinical (3501)
Press Release (26)
Prostate cancer (82)
Psychedelics (14)
Radiopharmaceuticals (134)
Rare diseases (291)
Real estate (2722)
Recruiting (19)
Regulatory (10906)
Reports (15)
Research institute (589)
Resumes & cover letters (56)
Rett syndrome (3)
RNA editing (6)
RSV (18)
Schizophrenia (63)
Series A (69)
Series B (40)
Service/supplier (3)
Sickle cell disease (44)
Special edition (10)
Spinal muscular atrophy (78)
Sponsored (10)
Startups (1687)
State (2)
Stomach cancer (4)
Supply chain (44)
Tariffs (67)
The Weekly (44)
Vaccines (222)
Venture capital (28)
Weight loss (136)
Women's health (19)
Worklife (4)
Date
Today (13)
Last 7 days (123)
Last 30 days (1060)
Last 365 days (11325)
2025 (10560)
2024 (13006)
2023 (14823)
2022 (20211)
2021 (20845)
2020 (19785)
2019 (15554)
2018 (12167)
2017 (14253)
2016 (13369)
2015 (15835)
2014 (12645)
2013 (10760)
2012 (11576)
2011 (12117)
2010 (11036)
Location
Africa (320)
Alabama (17)
Alaska (1)
Arizona (72)
Arkansas (3)
Asia (21127)
Australia (2770)
California (3035)
Canada (1431)
China (479)
Colorado (125)
Connecticut (124)
Delaware (113)
Europe (41779)
Florida (560)
Georgia (63)
Hawaii (1)
Idaho (12)
Illinois (309)
India (38)
Indiana (223)
Iowa (1)
Japan (200)
Kansas (75)
Kentucky (19)
Louisiana (5)
Maine (2)
Maryland (405)
Massachusetts (2512)
Michigan (43)
Minnesota (164)
Mississippi (1)
Missouri (32)
Montana (8)
Nebraska (6)
Nevada (16)
New Hampshire (7)
New Jersey (1302)
New Mexico (8)
New York (876)
North Carolina (567)
North Dakota (3)
Northern California (1337)
Ohio (90)
Oklahoma (5)
Oregon (17)
Pennsylvania (703)
Puerto Rico (10)
Rhode Island (15)
South America (520)
South Carolina (9)
Southern California (1338)
Tennessee (87)
Texas (424)
United States (12152)
Utah (61)
Virginia (146)
Washington D.C. (41)
Washington State (211)
West Virginia (1)
Wisconsin (36)
Wyoming (1)
279,739 Results for "synergy pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Skye’s CB1 Inhibitor Shows ‘Intriguing Synergy’ With Wegovy, Despite Mid-Stage Obesity Fail
Skye Bioscience’s nimacimab fell short of investor and company expectations, but showed encouraging weight-loss results when combined with Wegovy, according to analysts at William Blair.
October 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
November 14, 2025
·
3 min read
BioForest
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
Pattern Computer®, Inc. proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer program.
May 22, 2024
·
3 min read
Genetown
Phio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
Phio Pharmaceuticals Corp. today announced that in vivo data from a mouse model of colon cancer demonstrates target synergy-enhanced anti-tumor efficacy from a novel dual-targeting mouse PD-1 and CTLA-4 of an INTASYL coformulation.
April 18, 2023
·
4 min read
Sponsored
Best Pharmaceutical Label Manufacturers: Reviews and Comparisons
Selecting the ideal pharmaceutical label manufacturer requires careful consideration. This article compares leading companies, highlighting their strengths in regulatory compliance, material performance, serialization, innovation, and sustainability, to help you make an informed decision for your product’s safety and success.
October 27, 2025
·
6 min read
Press Releases
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
November 11, 2025
·
7 min read
Press Releases
CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
December 10, 2024
·
4 min read
Press Releases
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
November 14, 2025
·
6 min read
Press Releases
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
October 14, 2025
·
7 min read
Press Releases
Harrow to Acquire Melt Pharmaceuticals
September 29, 2025
·
8 min read
1 of 27,974
Next
